EMRIS Pharma
Developing topical treatments to prevent and treat skin toxicities from cancer therapies.
About
Technology stack
detected 2026-06-17No comments yet. Be the first to share your take.
What does EMRIS Pharma do?
EMRIS Pharma is developing a first-in-class topical solution to prevent skin toxicities associated with targeted cancer therapies, particularly EGFR inhibitors. Their innovation aims to improve patients' quality of life and treatment compliance by blocking anti-cancer drugs in the skin without interfering with the therapy. This addresses the significant unmet need of severe skin side effects experienced by 80%-90% of patients treated with these drugs.
Where is EMRIS Pharma headquartered?
EMRIS Pharma is headquartered in Tel Aviv, Israel.
When was EMRIS Pharma founded?
EMRIS Pharma was founded in 2021.
What industry does EMRIS Pharma operate in?
EMRIS Pharma operates in Life Sciences, Oncology, Biotech, MedTech, HealthTech, Drug Discovery.
How many employees does EMRIS Pharma have?
EMRIS Pharma has approximately 7 people on record.